好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Assessing Neurology Resident Teaching Skills through Objective Structured Examination (OSCE)
Neurologic 好色先生
P04 - (-)
243
BACKGROUND: Other specialties have used OSCE's to evaluate resident teaching skills, but there is a gap in the literature in this area for neurology. Based on the premise of "to really know a subject, teach it", we designed 2 teaching skills OSCE stations for neurology residents, utilizing teaching topics appropriate for senior residents (years 3 to 5 of training) and junior residents (years 1 to 3) respectively.
DESIGN/METHODS: In the senior neurology OSCE, the resident was observed teaching a standardized medical student how to perform lumbar puncture using a simulation model. In the junior neurology OSCE, the resident was observed teaching a standardized medical student how to perform the motor examination on a standardized patient. We used independent samples t-tests and linear regression to examine the effect of stage of training on standardized scores from the teaching OSCE stations.
RESULTS: There were 25 participants for the senior resident OSCE from neurology residency training programs from three universities. There were 6 participants in the junior resident OSCE from a single university. The mean standardized score was 0.60 (SD 0.19) for junior residents and 0.78 (SD 0.1) for senior residents (p = 0.0020). From linear regression, year of training was a significant predictor of standardized score (R = 0.049 for every one year increase; p = 0.018).
CONCLUSIONS: Objective Structured Examination (OSCE) stations are a promising way to evaluate neurology resident teaching skills. Senior residents obtained higher scores for their teaching ability when compared to junior residents.
Authors/Disclosures
Penelope S. Smyth, MD (University of Alberta)
PRESENTER
Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Smyth has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Canada. Dr. Smyth has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Short Term Exceptional Drug Therapy Program Alberta. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen-Idec. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Pharmaceuticals.
Kerri Schellenberg, MD No disclosure on file
Ted E. Roberts, MD (Div of Neurology, CSB Floor 7) No disclosure on file
Thomas J. Jeerakathil, MD, BSC (University of Alberta) The institution of Dr. Jeerakathil has received research support from University Hospital Foundation.
Gavin Giovannoni, MD (QMUL) Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.